Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Subjects and Atopic Dermatitis Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03634345
What this trial is testing

Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.

Who this might be right for
Dermatitis, Atopic
Pfizer 24
Early research (Phase 1)Study completedNCT01544348
What this trial is testing

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Who this might be right for
Allergic AsthmaAtopic DermatitisAllergic Rhinitis+1 more
MedImmune LLC 295
Early research (Phase 1)Study completedNCT04612062
What this trial is testing

A First-in-Human Study of CEE321 in Adult Subjects

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 28
Early research (Phase 1)Ended earlyNCT03689829
What this trial is testing

Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
HealthyAtopic Dermatitis
Lakefront Biotherapeutics NV 44
Early research (Phase 1)Study completedNCT06268860
What this trial is testing

Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

Who this might be right for
Atopic Dermatitis
Amgen 240
Early research (Phase 1)Study completedNCT05945810
What this trial is testing

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Who this might be right for
Atopic Dermatitis
Hangzhou Highlightll Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT03918980
What this trial is testing

Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064

Who this might be right for
Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis
Novartis Pharmaceuticals 185
Early research (Phase 1)Study completedNCT05461456
What this trial is testing

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more
OrchestratePharma GmbH 12
Early research (Phase 1)Study completedNCT05932888
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Looking for participantsNCT07453602
What this trial is testing

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Who this might be right for
Atopic Dermatitis (AD)Eczema
Arcutis Biotherapeutics, Inc. 125
Early research (Phase 1)Study completedNCT01423656
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

Who this might be right for
Atopic Dermatitis
LEO Pharma 102
Early research (Phase 1)Not Yet RecruitingNCT07042113
What this trial is testing

Two Different Formulations of 611 in Healthy Adult Subjects in China

Who this might be right for
Atopic Dermatitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02795832
What this trial is testing

Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ziarco Pharma Ltd 53
Early research (Phase 1)Study completedNCT04056130
What this trial is testing

Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Who this might be right for
Atopic Dermatitis (AD)
KoBioLabs 36
Early research (Phase 1)Study completedNCT06214481
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Who this might be right for
Atopic Dermatitis
Amgen 20
Early research (Phase 1)Study completedNCT06009094
What this trial is testing

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 80
Early research (Phase 1)Not Yet RecruitingNCT07698756
What this trial is testing

A Clinical Study of HRS-8797 in Healthy Participants

Who this might be right for
Atopic Dermatitis
Chengdu Suncadia Medicine Co., Ltd. 74
Early research (Phase 1)Study completedNCT04256174
What this trial is testing

AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akesobio Australia Pty Ltd 80
Early research (Phase 1)Study completedNCT05803902
What this trial is testing

An Evaluation of 9MW1911 Injection in Healthy Subjects

Who this might be right for
AsthmaCOPDAtopic Dermatitis
Mabwell (Shanghai) Bioscience Co., Ltd. 48
Early research (Phase 1)Study completedNCT07103369
What this trial is testing

A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 64
Next Page